Literature DB >> 3953705

Family trait analysis: a case-control study of 43 women with endometriosis and their best friends.

K Lamb, R G Hoffmann, T R Nichols.   

Abstract

Analyses of lineage patterns show that for 43 women with endometriosis who reported that other family members have the disease, the vast majority of these familial cases involve the maternal lineage (79% to 93%). Of these women 34.9% of their mothers and 21.2% of their sisters were affected. With use of these rates, expected rates for first-degree relatives in a general population of women with endometriosis were determined. These rates were 6.2% and 3.8%, respectively; in combination, these rates yield an overall risk of 4.9% for first-degree relatives. Prior studies estimated this overall risk to be 6.9%; however, z scores determined that these rates do not differ statistically. Rates for second-degree maternal relatives are reported for grandmothers and aunts (0.4% compared to 3.1%, respectively), thus expanding results of former studies. In combination, an overall risk of 1.9% is estimated for second-degree relatives, as measured.

Entities:  

Mesh:

Year:  1986        PMID: 3953705     DOI: 10.1016/0002-9378(86)90608-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  Familial risk among patients with endometriosis.

Authors:  R M dos Reis; M F de Sá; M D de Moura; A A Nogueira; J U Ribeiro; E S Ramos; R A Ferriani
Journal:  J Assist Reprod Genet       Date:  1999-10       Impact factor: 3.412

Review 2.  Epidemiology of endometriosis.

Authors:  P Mangtani; M Booth
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

3.  A higher prevalence of endometriosis among Asian women does not contribute to poorer IVF outcomes.

Authors:  Ayae Yamamoto; Erica B Johnstone; Michael S Bloom; Heather G Huddleston; Victor Y Fujimoto
Journal:  J Assist Reprod Genet       Date:  2017-04-17       Impact factor: 3.412

4.  Family incidence of endometriosis in first-, second-, and third-degree relatives: case-control study.

Authors:  Kazem Nouri; Johannes Ott; Birgitt Krupitz; Johannes C Huber; Rene Wenzl
Journal:  Reprod Biol Endocrinol       Date:  2010-07-11       Impact factor: 5.211

5.  Shift work, hCLOCK T3111C polymorphism, and endometriosis risk.

Authors:  Jennifer L Marino; Victoria L Holt; Chu Chen; Scott Davis
Journal:  Epidemiology       Date:  2008-05       Impact factor: 4.822

6.  Advances in the genetics of endometriosis.

Authors:  Erica C Dun; Robert N Taylor; Fritz Wieser
Journal:  Genome Med       Date:  2010-10-14       Impact factor: 11.117

7.  The role of IL‑16 gene polymorphisms in endometriosis.

Authors:  Michail Matalliotakis; Maria I Zervou; Elias Eliopoulos; Charoula Matalliotaki; Nilufer Rahmioglu; Ioannis Kalogiannidis; Krina Zondervan; Demetrios A Spandidos; Ioannis Matalliotakis; George N Goulielmos
Journal:  Int J Mol Med       Date:  2018-01-09       Impact factor: 4.101

Review 8.  Extrapelvic endometriosis: a rare entity or an under diagnosed condition?

Authors:  Nikolaos Machairiotis; Aikaterini Stylianaki; Georgios Dryllis; Paul Zarogoulidis; Paraskevi Kouroutou; Nikolaos Tsiamis; Nikolaos Katsikogiannis; Eirini Sarika; Nikolaos Courcoutsakis; Theodora Tsiouda; Andreas Gschwendtner; Konstantinos Zarogoulidis; Leonidas Sakkas; Aggeliki Baliaka; Christodoulos Machairiotis
Journal:  Diagn Pathol       Date:  2013-12-02       Impact factor: 2.644

9.  Effect of octreotide on endometriosis in acromegaly: Case report with review of literature.

Authors:  Seerat Singh; Aditi Anupam Chakravarty; Smita Manchanda; Renuka Mallik; Shweta Chopra; Ajay Ajmani; Bindu Kulshreshtha
Journal:  Indian J Endocrinol Metab       Date:  2014-03

10.  The role of gene polymorphisms in endometriosis.

Authors:  Michail Matalliotakis; Maria I Zervou; Charoula Matalliotaki; Nilufer Rahmioglu; George Koumantakis; Ioannis Kalogiannidis; Ioannis Prapas; Krina Zondervan; Demetrios A Spandidos; Ioannis Matalliotakis; George N Goulielmos
Journal:  Mol Med Rep       Date:  2017-08-29       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.